• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

    4/29/24 9:00:00 AM ET
    $ACHV
    $ACON
    $ALCO
    $APCX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical Specialities
    Health Care
    Get the next $ACHV alert in real time by email

    LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las Vegas, NV.

    Event website: https://planetmicrocapshowcase.com

    The Planet MicroCap Showcase begins on Tuesday, April 30, 2024 with the "MicroCap Investing Workshop" starting at 12:00pm PST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders, followed by 96 MicroCap public and private company presentations on Wednesday, May 1, 2024, and 1x1 meetings on Thursday, May 2, 2024.

    If you would like to attend and participate in the Planet MicroCap Showcase, please register here to attend this IN-PERSON CONFERENCE and book 1x1 meetings with presenting companies: https://planetmicrocapshowcase.com/signup

    The "MicroCap Investing Workshop" and Full Agenda are available here: https://planetmicrocapshowcase.com/agenda

    On Wednesday, May 1, 2024, the following issuers will be presenting their companies. Below are the webcasting links to view those presentations if you can't attend the showcase live.

    CompanyExchange: SymbolWebcast Link
    22nd Century Group, Inc.NASDAQ: XXIIhttps://www.webcaster4.com/Webcast/Page/3026/50181
    Achieve Life Sciences, Inc.NASDAQ: ACHVhttps://www.webcaster4.com/Webcast/Page/3026/50403
    Aclarion, Inc.NASDAQ: ACONhttps://www.webcaster4.com/Webcast/Page/3026/50174
    ADM Endeavors, Inc.OTCQB: ADMQhttps://www.webcaster4.com/Webcast/Page/3026/50123
    AgEagle Aerial Systems Inc.NYSE American: UAVShttps://www.webcaster4.com/Webcast/Page/3026/50200
    Alico, Inc.NASDAQ: ALCOhttps://www.webcaster4.com/Webcast/Page/3026/50159
    Altigen Communications - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comOTCQB: ATGNhttps://www.webcaster4.com/Webcast/Page/3026/50120
    AppTech Payments Corp.NASDAQ: APCXhttps://www.webcaster4.com/Webcast/Page/3026/50338
    Atossa TherapeuticsNASDAQ: ATOShttps://www.webcaster4.com/Webcast/Page/3026/50195
    BeneficientNASDAQ: BENFhttps://www.webcaster4.com/Webcast/Page/3026/50307
    Big Watt DigitalPRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50310
    BioStem Technologies, Inc.OTC PINK: BSEMhttps://www.webcaster4.com/Webcast/Page/3026/50201
    BitMine Immersion Technologies, Inc.OTCQX: BMNRhttps://www.webcaster4.com/Webcast/Page/3026/50408
    BOXABLPRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50173
    Bragg Gaming Group Inc.NASDAQ: BRAG / TSX: BRAGhttps://www.webcaster4.com/Webcast/Page/3026/50415
    Byrna Technologies Inc.NASDAQ: BYRNhttps://www.webcaster4.com/Webcast/Page/3026/50188
    Can-Fite BioPharma Ltd.NYSE American: CANF / TASE: CANFhttps://www.webcaster4.com/Webcast/Page/3026/50191
    Cell TechnologiesPRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50178
    Checkit PLCLSE: CKThttps://www.webcaster4.com/Webcast/Page/3026/50179
    Cingulate Inc.NASDAQ: CINGhttps://www.webcaster4.com/Webcast/Page/3026/50308
    Combat Sports EntertainmentPRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50413
    Corero Network Security plcLSE: CNS / OTCQB: DDOSFhttps://www.webcaster4.com/Webcast/Page/3026/50171
    Creative Realities, Inc.NASDAQ: CREXhttps://www.webcaster4.com/Webcast/Page/3026/50150
    Crexendo, Inc. - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comNASDAQ: CXDOhttps://www.webcaster4.com/Webcast/Page/3026/50118
    Cytta Corp.OTCQB: CYCAhttps://www.webcaster4.com/Webcast/Page/3026/50306
    Damon Motors Inc.PRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50367
    DATA Communications Management - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comTSX: DCM / OTCQX: DCMDFhttps://www.webcaster4.com/Webcast/Page/3026/50115
    DayDayCookNYSE American: DDChttps://www.webcaster4.com/Webcast/Page/3026/50456
    DeFi Technologies Inc.NEO: DEFI / OTC: DEFTFhttps://www.webcaster4.com/Webcast/Page/3026/50180
    DMG Blockchain Solutions Inc.TSX-V: DMGI / OTCQB: DMGGFhttps://www.webcaster4.com/Webcast/Page/3026/50158
    Dolphin Entertainment, Inc.NASDAQ: DLPNhttps://www.webcaster4.com/Webcast/Page/3026/50192
    Elutia Inc.NASDAQ: ELUThttps://www.webcaster4.com/Webcast/Page/3026/50368
    Envoy Medical, Inc.NASDAQ: COCHhttps://www.webcaster4.com/Webcast/Page/3026/50121
    Fathom Holdings Inc.NASDAQ: FTHMhttps://www.webcaster4.com/Webcast/Page/3026/50404
    Fireside Q&A with Biorem and Mathieu Martin, Rivemont MicroCap FundTSX-V: BRMhttps://www.webcaster4.com/Webcast/Page/3026/50154
    Fireside Q&A with BioSyent and Mathieu Martin, Rivemont MicroCap FundTSX-V: RXhttps://www.webcaster4.com/Webcast/Page/3026/50153
    Fireside Q&A with BQE Water Inc. and Mathieu Martin, Rivemont MicroCap FundTSX-V: BQEhttps://www.webcaster4.com/Webcast/Page/3026/50297
    Fireside Q&A with Mama's Creations and Ben Claremon, Host of Compounders PodcastNASDAQ: MAMAhttps://www.webcaster4.com/Webcast/Page/3026/50098
    Fireside Q&A with OneSoft Solutions and Mathieu Martin, Rivemont MicroCap FundTSX-V: OSS / OTCQB: OSSIFhttps://www.webcaster4.com/Webcast/Page/3026/50131
    Fireside Q&A with Sabio Holdings Inc. and Mathieu Martin, Rivemont MicroCap FundTSX-V: SBIO / OTCQX: SABOFhttps://www.webcaster4.com/Webcast/Page/3026/50156
    Fireside Q&A with Yerbaé Brands Corp. and Mathieu Martin, Rivemont MicroCap FundTSX-V: YERB.U / OTCQX: YERBFhttps://www.webcaster4.com/Webcast/Page/3026/50155
    First Wave BioPharma, Inc.NASDAQ: FWBIhttps://www.webcaster4.com/Webcast/Page/3026/50293
    Foremost Lithium Resource & Technology Ltd.NASDAQ: FMST / CSE: FAThttps://www.webcaster4.com/Webcast/Page/3026/50302
    FreightCar America, Inc.NASDAQ: RAILhttps://www.webcaster4.com/Webcast/Page/3026/50295
    Galaxy Gaming, Inc.OTCQB: GLXZhttps://www.webcaster4.com/Webcast/Page/3026/50296
    Greenidge Generation Holdings Inc.NASDAQ: GREEhttps://www.webcaster4.com/Webcast/Page/3026/50312
    Greystone Logistics, Inc.OTCQB: GLGIhttps://www.webcaster4.com/Webcast/Page/3026/50313
    Guardforce AI Co.NASDAQ: GFAIhttps://www.webcaster4.com/Webcast/Page/3026/50162
    HEALWELL AI Inc.TSX: AIDX / OTCQX: HWAIFhttps://www.webcaster4.com/Webcast/Page/3026/50168
    Heritage Global, Inc. - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comNASDAQ: HGBLhttps://www.webcaster4.com/Webcast/Page/3026/50116
    Hypha Labs, Inc.OTCQB: DIGPhttps://www.webcaster4.com/Webcast/Page/3026/50309
    IntellistemPRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50175
    Intouch Insight - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comTSX-V: INX / OTCQX: INXSFhttps://www.webcaster4.com/Webcast/Page/3026/50114
    Issuer Direct CorporationNYSE American: ISDRhttps://www.webcaster4.com/Webcast/Page/3026/50170
    Journey Medical CorporationNASDAQ: DERMhttps://www.webcaster4.com/Webcast/Page/3026/50366
    La Rosa Holdings Corp.NASDAQ: LRHChttps://www.webcaster4.com/Webcast/Page/3026/50169
    Lakeland Industries - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comNASDAQ: LAKEhttps://www.webcaster4.com/Webcast/Page/3026/50117
    LiveWorld, Inc.OTC Markets: LVWDhttps://www.webcaster4.com/Webcast/Page/3026/50304
    Longeveron Inc.NASDAQ: LGVNhttps://www.webcaster4.com/Webcast/Page/3026/50416
    LuxUrban HotelsNASDAQ: LUXH1x1s ONLY
    McCoy Global, Inc.TSX: MCBhttps://www.webcaster4.com/Webcast/Page/3026/50151
    MGID Inc.PRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50311
    Music Royalties Inc.PRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50505
    MustGrow Biologics Corp.TSX-V: MGRO / OTC: MGROFhttps://www.webcaster4.com/Webcast/Page/3026/50185
    NanoVibronix, Inc.NASDAQ: NAOVhttps://www.webcaster4.com/Webcast/Page/3026/50182
    Nephros, Inc.NASDAQ: NEPHhttps://www.webcaster4.com/Webcast/Page/3026/50161
    NEXGEL, Inc.NASDAQ: NXGLhttps://www.webcaster4.com/Webcast/Page/3026/50184
    Nova Leap HealthTSX-V: NLHhttps://www.webcaster4.com/Webcast/Page/3026/50163
    Paragon Technologies, Inc.OTC Pink: PGNThttps://www.webcaster4.com/Webcast/Page/3026/50193
    Perfect Corp.NYSE: PERFhttps://www.webcaster4.com/Webcast/Page/3026/50177
    Pineapple Financial Inc.NYSE American: PAPLhttps://www.webcaster4.com/Webcast/Page/3026/50299
    Precision Optics Corporation, Inc.NASDAQ: POCIhttps://www.webcaster4.com/Webcast/Page/3026/50294
    ProPhase LabsNASDAQ: PRPHhttps://www.webcaster4.com/Webcast/Page/3026/50164
    Quest Patent Research CorporationOTCQB: QPRChttps://www.webcaster4.com/Webcast/Page/3026/50176
    RedCloud TechnologyPRIVATE COMPANYhttps://www.webcaster4.com/Webcast/Page/3026/50112
    Richardson Electronics - "Top Tier Track" Q&A with Maj Soueidan, GeoInvesting.comNASDAQ: RELLhttps://www.webcaster4.com/Webcast/Page/3026/50119
    Sacks Parente Golf, Inc.NASDAQ: SPGChttps://www.webcaster4.com/Webcast/Page/3026/50198
    Shelly Group ADFrankfurt: SLYGhttps://www.webcaster4.com/Webcast/Page/3026/50122
    Shuttle PharmaceuticalsNASDAQ: SHPHhttps://www.webcaster4.com/Webcast/Page/3026/50183
    SinglePoint, Inc.CBOE: SINGhttps://www.webcaster4.com/Webcast/Page/3026/50160
    Strata Skin SciencesNASDAQ: SSKNhttps://www.webcaster4.com/Webcast/Page/3026/50402
    Tantalus SystemsTSX: GRIDhttps://www.webcaster4.com/Webcast/Page/3026/50189
    Tego Cyber Inc.OTCQB: TGCBhttps://www.webcaster4.com/Webcast/Page/3026/50458
    Tharimmune, Inc.NASDAQ: THARhttps://www.webcaster4.com/Webcast/Page/3026/50301
    Tonix PharmaceuticalsNASDAQ: TNXPhttps://www.webcaster4.com/Webcast/Page/3026/50506
    TruGolf Holdings, Inc.NASDAQ: TRUGhttps://www.webcaster4.com/Webcast/Page/3026/50430
    Turnium Technology Group Inc.TSX-V: TTGIhttps://www.webcaster4.com/Webcast/Page/3026/50405
    UGE InternationalTSX-V: UGE / OTCQB: UGEIFhttps://www.webcaster4.com/Webcast/Page/3026/50134
    Urban Infrastructure Group Inc.TSX-V: UIGhttps://www.webcaster4.com/Webcast/Page/3026/50406
    VCI Global LimitedNASDAQ: VCIGhttps://www.webcaster4.com/Webcast/Page/3026/50457
    VinanzPRIVATE COMPANY1x1s ONLY
    Vox Royalty Corp.TSX: VOXR / NASDAQ: VOXRhttps://www.webcaster4.com/Webcast/Page/3026/50152
    WiSA Technologies, Inc.NASDAQ: WISAhttps://www.webcaster4.com/Webcast/Page/3026/50300
    Wishpond TechnologiesTSX-V: WISH / OTCQX: WPNDFhttps://www.webcaster4.com/Webcast/Page/3026/50167
    Xcel Brands, Inc.NASDAQ: XELBhttps://www.webcaster4.com/Webcast/Page/3026/50166
    Xcyte Digital Corp.TSX-V: XCYThttps://www.webcaster4.com/Webcast/Page/3026/50149

    We would like to thank our VEGAS 2024 sponsors for their support:

    Premier Sponsors

    Acuitas Investments

    Bancroft Capital

    Cboe

    Lucosky Brookman

    Marcum LLP

    PULLP

    Spartan Capital

    SumZero

    Gold Sponsors

    Alexander Capital

    Centurion One Capital

    CORE IR

    Eventus Advisory Group

    FKBR

    GeoInvesting.com

    Issuer Direct Corporation

    Lake Street Capital Markets

    Lowenstein Sandler

    NSi Insurance Group

    Sichenzia Ross Ference Carmel LLP

    Sophic Capital

    The Money Channel NYC

    Water Tower Research

    Exhibitor Sponsors

    1606 Corp.

    Adelaide Capital

    Assurtrak

    B. Riley Securities

    Bevilacqua PLLC

    The Benchmark Company

    Bush & Associates CPA

    Canadian Securities Exchange (CSE)

    Churchwell Insurance Agency

    Colonial Stock Transfer

    Continental Stock Transfer & Trust

    Coral Capital Advisors

    Darrow Associates

    Edgar Agents

    Elev8 New Media

    Equisolve

    Glendale Securities

    Grassi & Associates

    Harbor Access

    Hayden IR

    IMS Investor Relations

    Independent Investment Research

    JH Darbie & Co.

    Joseph Gunnar & Co., LLC

    Kreit & Chiu CPA LLP

    Lytham Partners

    MarcumAsia

    MMTec (NASDAQ:MTC)

    Moody Capital

    MZ Group

    The Nuvo Group

    Odyssey Trust Company

    OTC Markets Group

    PCG Advisory

    PondelWilkinson

    Porter LeVay & Rose

    Procopio

    R.F. Lafferty & Co., Inc.

    SheppardMullin

    Skyline Corporate Communications

    SLS Group

    Weinberg & Company

    About Planet MicroCap

    Planet MicroCap is a global multimedia, publishing financial news and events company covering the MicroCap market. Since 1998, Planet MicroCap continues to cultivate an active and engaged community of folks that are interested in learning about and staying ahead of the curve in the MicroCap space. If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup

    Planet MicroCap
    [email protected]

    SOURCE: Planet MicroCap



    View the original press release on accesswire.com

    Get the next $ACHV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHV
    $ACON
    $ALCO
    $APCX

    CompanyDatePrice TargetRatingAnalyst
    Achieve Life Sciences Inc.
    $ACHV
    11/25/2025$19.00Mkt Outperform
    Citizens JMP
    Bragg Gaming Group Inc.
    $BRAG
    10/17/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Achieve Life Sciences Inc.
    $ACHV
    8/21/2025$12.00Buy
    H.C. Wainwright
    Bragg Gaming Group Inc.
    $BRAG
    8/18/2025Buy → Hold
    The Benchmark Company
    Byrna Technologies Inc.
    $BYRN
    7/16/2025$39.00Buy
    Craig Hallum
    Achieve Life Sciences Inc.
    $ACHV
    11/14/2024$12.00Buy
    Rodman & Renshaw
    Achieve Life Sciences Inc.
    $ACHV
    9/27/2024$20.00Strong Buy
    Raymond James
    Byrna Technologies Inc.
    $BYRN
    8/28/2024$14.00Buy
    ROTH MKM
    More analyst ratings

    $ACHV
    $ACON
    $ALCO
    $APCX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACHV
    $ACON
    $ALCO
    $APCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook

    SEATTLE, Feb. 11, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet need, today issued a letter to Shareholders from Steven Quay, M.D., Ph.D., Atossa Therapeutics President and Chief Executive Officer, providing an update on the Company's clinical programs and recent events. The full text of the letter follows: To our valued shareholders, In looking back on 2025, Atossa made meaningful progress advancing proprietary oral (Z)-en

    2/11/26 8:30:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Invisible Shield: 5 Stocks Solving The $16B Blind Spot

    Issued on behalf of VisionWave Holdings, Inc. NEW YORK, Feb. 6, 2026 /PRNewswire/ -- USA News Group News Commentary – Surveillance has evolved from passive recording to predictive threat detection. AI-powered analytics are now deeply integrated into smart city deployments to secure commercial facilities and critical infrastructure[1]. This technological leap coincides with a major regulatory shift: federal frameworks are standardizing Level 4 safety protocols while states accelerate robotaxi permitting in geofenced urban zones[2]. Leading this convergence of RF sensing, LiDAR precision, and aerial ISR are VisionWave Holdings Inc. (NASDAQ:VWAV), SaverOne (NASDAQ:SVRE), Innoviz Technologies (N

    2/6/26 11:54:00 AM ET
    $CSAI
    $INVZ
    $SVRE
    Computer Software: Programming Data Processing
    Technology
    Auto Parts:O.E.M.
    Consumer Discretionary

    Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program

    Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today reaffirmed its strong market position around its Duchenne Muscular Dystrophy (DMD) program following  yesterday's congressional announcement that it had passed a five-year reauthorization of the Rare Pediatric Disease Priority Review Voucher ("PRV") Program. The program extends the Company's ability to be eligible to receive

    2/5/26 8:30:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHV
    $ACON
    $ALCO
    $APCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Medical Officer Rubinstein Mark Lawrence

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    1/30/26 4:10:02 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Chief Financial Officer Oki Mark K

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    1/30/26 4:09:02 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Chief Commercial Officer Xinos Jaime

    4 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    1/30/26 4:08:02 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHV
    $ACON
    $ALCO
    $APCX
    SEC Filings

    View All

    Atossa Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ATOSSA THERAPEUTICS, INC. (0001488039) (Filer)

    2/11/26 8:45:24 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AgEagle Aerial Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AgEagle Aerial Systems Inc. (0000008504) (Filer)

    2/6/26 4:55:28 PM ET
    $UAVS
    Aerospace
    Industrials

    SEC Form 10-K filed by Byrna Technologies Inc.

    10-K - Byrna Technologies Inc. (0001354866) (Filer)

    2/5/26 4:17:43 PM ET
    $BYRN
    Industrial Machinery/Components
    Miscellaneous

    $ACHV
    $ACON
    $ALCO
    $APCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens JMP initiated coverage on Achieve Life Sciences with a new price target

    Citizens JMP initiated coverage of Achieve Life Sciences with a rating of Mkt Outperform and set a new price target of $19.00

    11/25/25 8:38:19 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Bragg Gaming Group downgraded by Citizens JMP

    Citizens JMP downgraded Bragg Gaming Group from Mkt Outperform to Mkt Perform

    10/17/25 8:25:11 AM ET
    $BRAG
    Office Equipment/Supplies/Services
    Technology

    H.C. Wainwright initiated coverage on Achieve Life Sciences with a new price target

    H.C. Wainwright initiated coverage of Achieve Life Sciences with a rating of Buy and set a new price target of $12.00

    8/21/25 8:16:03 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHV
    $ACON
    $ALCO
    $APCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lord Albert L bought $52,132 worth of shares (120,000 units at $0.43), increasing direct ownership by 4% to 3,016,194 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    12/4/25 7:22:39 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Ness Brent bought $62 worth of shares (10 units at $6.20), increasing direct ownership by 1,000% to 11 units (SEC Form 4)

    4 - Aclarion, Inc. (0001635077) (Issuer)

    12/1/25 5:00:02 PM ET
    $ACON
    Medical Specialities
    Health Care

    Director Lord Albert L bought $23,347 worth of shares (57,500 units at $0.41), increasing direct ownership by 2% to 2,896,194 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    11/28/25 5:11:59 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ACON
    $ALCO
    $APCX
    Financials

    Live finance-specific insights

    View All

    EagleNXT Expands European Defense Footprint with 15-Unit eBee X Drone Order from Tier-1 Integrator

    Fixed Wing Drones Capable of Providing Training, ISR Missions for Leading Aerospace Provider ALLEN, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (the "Company" or "EagleNXT") (NYSE:UAVS), a leading provider of full stack drone, sensors and software solutions for customers worldwide in the commercial and government verticals, today announces the sale of 15 eBee X fixed wing drones to a Europe-based defense integrator. The eBee X is a lightweight, NDAA-compliant, high-performance mapping and surveying platform known for its exceptional endurance (up to 90 minutes), large-area coverage (up to 1,250 acres per flight), and centimeter-level accuracy with

    2/5/26 8:00:00 AM ET
    $UAVS
    Aerospace
    Industrials

    Byrna Technologies Reports Record Fiscal Fourth Quarter and Full Year 2025 Results; Full Year Revenue Up 38% Year-over-Year

    ANDOVER, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. ("Byrna" or the "Company") (NASDAQ:BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today reported select financial results for its fiscal fourth quarter ("Q4 2025") and full year ended November 30, 2025. Fiscal Fourth Quarter 2025 and Recent Operational Highlights Surpassed 750,000 launchers sold since inception, increasing cumulative unit sales by more than 250,000 units during fiscal 2025.Expanded monthly production capacity to 20,000 units to support growing demand, including larger than anticipated dealer

    2/5/26 8:00:00 AM ET
    $BYRN
    Industrial Machinery/Components
    Miscellaneous

    Alico, Inc. Announces Financial Results for the First Quarter Ended December 31, 2025

    Company Closed $7.7 million of Land Sales in First Quarter; Total Land Sales Reach $34.5 million Year-to-Date Through January 2026 Farmable land Utilization Reaches 97% Following Completion of Lease Agreements in January 2026 Land Sales and Operating Performance Strengthen Cash Position, Creating Strategic Capital Deployment Optionality Development Pipeline Moves Forward with Local Corkscrew Grove Entitlement Decision By County Expected in 2026 FORT MYERS, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. ("Alico", the "Company", "we", "us" or "our") (NASDAQ:ALCO) today announced financial results for the first quarter ended December 31, 2025. Management Comments John Kiernan, Pres

    2/4/26 4:05:00 PM ET
    $ALCO

    $ACHV
    $ACON
    $ALCO
    $APCX
    Leadership Updates

    Live Leadership Updates

    View All

    Atossa Therapeutics Issues Letter to Shareholders Highlighting 2025 Accomplishments and 2026 Outlook

    SEATTLE, Feb. 11, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet need, today issued a letter to Shareholders from Steven Quay, M.D., Ph.D., Atossa Therapeutics President and Chief Executive Officer, providing an update on the Company's clinical programs and recent events. The full text of the letter follows: To our valued shareholders, In looking back on 2025, Atossa made meaningful progress advancing proprietary oral (Z)-en

    2/11/26 8:30:00 AM ET
    $ATOS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

    Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion's commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the

    12/2/25 8:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACHV
    $ACON
    $ALCO
    $APCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Beneficient

    SC 13G/A - Beneficient (0001775734) (Subject)

    11/14/24 5:07:46 PM ET
    $BENF
    Finance: Consumer Services
    Finance